Literature DB >> 24998474

Sex, epilepsy, and epigenetics.

Irfan A Qureshi1, Mark F Mehler2.   

Abstract

Epilepsy refers to a heterogeneous group of disorders that are associated with a wide range of pathogenic mechanisms, seizure manifestations, comorbidity profiles, and therapeutic responses. These characteristics are all influenced quite significantly by sex. As with other conditions exhibiting such patterns, sex differences in epilepsy are thought to arise-at the most fundamental level-from the "organizational" and "activational" effects of sex hormones as well as from the direct actions of the sex chromosomes. However, our understanding of the specific molecular, cellular, and network level processes responsible for mediating sex differences in epilepsy remains limited. Because increasing evidence suggests that epigenetic mechanisms are involved both in epilepsy and in brain sexual dimorphism, we make the case here that analyzing epigenetic regulation will provide novel insights into the basis for sex differences in epilepsy.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chromatin; DNA methylation; Epigenetic; Epilepsy; Histone; Non-coding RNA

Mesh:

Year:  2014        PMID: 24998474      PMCID: PMC4252397          DOI: 10.1016/j.nbd.2014.06.019

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  116 in total

Review 1.  Noncoding RNAs: couplers of analog and digital information in nervous system function?

Authors:  Georges St Laurent; Claes Wahlestedt
Journal:  Trends Neurosci       Date:  2007-11-08       Impact factor: 13.837

Review 2.  X-inactivation, imprinting, and long noncoding RNAs in health and disease.

Authors:  Jeannie T Lee; Marisa S Bartolomei
Journal:  Cell       Date:  2013-03-14       Impact factor: 41.582

3.  Epigenetic alterations regulate estradiol-induced enhancement of memory consolidation.

Authors:  Zaorui Zhao; Lu Fan; Karyn M Frick
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-08       Impact factor: 11.205

4.  A novel estrogen receptor-microRNA 190a-PAR-1-pathway regulates breast cancer progression, a finding initially suggested by genome-wide analysis of loci associated with lymph-node metastasis.

Authors:  Hou-Wei Chu; Chun-Wen Cheng; Wen-Cheng Chou; Ling-Yueh Hu; Hsiao-Wei Wang; Chia-Ni Hsiung; Huan-Ming Hsu; Pei-Ei Wu; Ming-Feng Hou; Chen-Yang Shen; Jyh-Cherng Yu
Journal:  Hum Mol Genet       Date:  2013-09-05       Impact factor: 6.150

5.  Epigenetic regulation of estrogen receptor beta expression in the rat cortex during aging.

Authors:  Jenne M Westberry; Amanda L Trout; Melinda E Wilson
Journal:  Neuroreport       Date:  2011-06-22       Impact factor: 1.837

6.  BRD2 (RING3) is a probable major susceptibility gene for common juvenile myoclonic epilepsy.

Authors:  Deb K Pal; Oleg V Evgrafov; Paula Tabares; Fengli Zhang; Martina Durner; David A Greenberg
Journal:  Am J Hum Genet       Date:  2003-06-25       Impact factor: 11.025

Review 7.  Guided by RNAs: X-inactivation as a model for lncRNA function.

Authors:  John E Froberg; Lin Yang; Jeannie T Lee
Journal:  J Mol Biol       Date:  2013-06-28       Impact factor: 5.469

Review 8.  Epigenetics: judge, jury and executioner of stem cell fate.

Authors:  James R Tollervey; Victoria V Lunyak
Journal:  Epigenetics       Date:  2012-07-18       Impact factor: 4.528

9.  Reduced mature microRNA levels in association with dicer loss in human temporal lobe epilepsy with hippocampal sclerosis.

Authors:  Ross C McKiernan; Eva M Jimenez-Mateos; Isabella Bray; Tobias Engel; Gary P Brennan; Takanori Sano; Zuzanna Michalak; Catherine Moran; Norman Delanty; Michael Farrell; Donncha O'Brien; Robert Meller; Roger P Simon; Raymond L Stallings; David C Henshall
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

10.  A homozygous mutation in human PRICKLE1 causes an autosomal-recessive progressive myoclonus epilepsy-ataxia syndrome.

Authors:  Alexander G Bassuk; Robyn H Wallace; Aimee Buhr; Andrew R Buller; Zaid Afawi; Masahito Shimojo; Shingo Miyata; Shan Chen; Pedro Gonzalez-Alegre; Hilary L Griesbach; Shu Wu; Marcus Nashelsky; Eszter K Vladar; Dragana Antic; Polly J Ferguson; Sebahattin Cirak; Thomas Voit; Matthew P Scott; Jeffrey D Axelrod; Christina Gurnett; Azhar S Daoud; Sara Kivity; Miriam Y Neufeld; Aziz Mazarib; Rachel Straussberg; Simri Walid; Amos D Korczyn; Diane C Slusarski; Samuel F Berkovic; Hatem I El-Shanti
Journal:  Am J Hum Genet       Date:  2008-10-30       Impact factor: 11.025

View more
  3 in total

Review 1.  Practical approaches to adverse outcome pathway development and weight-of-evidence evaluation as illustrated by ecotoxicological case studies.

Authors:  Kellie A Fay; Daniel L Villeneuve; Carlie A LaLone; You Song; Knut Erik Tollefsen; Gerald T Ankley
Journal:  Environ Toxicol Chem       Date:  2017-03-31       Impact factor: 3.742

Review 2.  Epigenetics and epilepsy prevention: The therapeutic potential of adenosine and metabolic therapies.

Authors:  Detlev Boison; Jong M Rho
Journal:  Neuropharmacology       Date:  2019-08-13       Impact factor: 5.250

3.  Genetically Epilepsy-Prone Rats Display Anxiety-Like Behaviors and Neuropsychiatric Comorbidities of Epilepsy.

Authors:  Brittany L Aguilar; Ludise Malkova; Prosper N'Gouemo; Patrick A Forcelli
Journal:  Front Neurol       Date:  2018-06-27       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.